CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. - Wikidata - wikimedia - TriplyDB

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

http://www.wikidata.org/entity/Q37465068

about

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease Role of HIV in amyloid metabolism HIV and aging: effects on the central nervous system Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders Soluble and cell-associated insulin receptor dysfunction correlates with severity of HAND in HIV-infected women HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).Intercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder.Pathogenesis of HIV in the central nervous system Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.Curcumin ameliorates hippocampal neuron damage induced by human immunodeficiency virus-1 HIV-associated neurocognitive disorder.Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Asymptomatic neurocognitive disorders in patients infected by HIV: fact or fiction?The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.The role of tau protein in HIV-associated neurocognitive disorders Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults.Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.Autophagy in dementias.The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment.Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats.11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.Nef exosomes isolated from the plasma of individuals with HIV-associated dementia (HAD) can induce Aβ(1-42) secretion in SH-SY5Y neural cells Impact of age on markers of HIV-1 disease Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders APOE ε 4 allele and CSF APOE on cognition in HIV-infected subjects Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production.Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia Antisense reduction of tau in adult mice protects against seizures Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders

P2860

Q26770397-33818E85-C5D1-444C-A9E2-79A4BA8E03AF Q26824179-148B6FF2-E156-456B-9496-24E5BC571A09 Q27025018-EB9989FA-C3BA-480D-A72E-68188D60D30B Q28082139-BE1B99CA-973A-4E37-B8E5-082CC9FA17BD Q28729739-589ECFA4-79E5-4620-97D3-0B00008D9EE6 Q30234305-4DCE0D8C-E1B2-4965-8464-D9D81CFF79CB Q31153188-DD2EE6B8-96BA-42C8-ABB9-006E29183E69 Q31159582-61274C7A-5339-4757-89AB-A35E15528E1E Q33714228-0628856D-62D9-437C-BC4E-45A0B1D99ACA Q33781978-2136E9D6-BF9A-4DDD-81B6-94FDA611C706 Q33863368-477074EC-8B10-4735-874C-EAFC9421BA9F Q33937629-A9EC9DE7-8467-4EA8-A32E-DDD9882E1A4E Q33939729-0674FA98-E29E-4A5C-8C74-3F635576EBBF Q34002937-F2523194-EF14-4CAB-ACCC-BAA20DA26872 Q34037622-49D583F0-455E-4BAB-85DE-B85537090909 Q34113118-0E1AE3CE-96D6-430D-9BD9-2FAAD91B5F9C Q34296479-8557DF6D-1369-4D1D-9671-8C9877F8D149 Q34315258-215B2794-C8D2-476B-A742-7C5F8261530C Q34410713-330B8E93-D26E-4498-9C2C-3DFE76C4A358 Q34540333-80CF465D-E38F-41B7-8B69-9E347815DDAC Q34776835-8CCE6B6F-91B7-4160-B028-9FD5CA016BED Q35171279-DD61CEDF-0C90-479F-93BD-CD63B1789194 Q35186413-B864A869-CFCD-47AC-8A42-C750A3D259FC Q35187881-7E43CD7E-DEBB-41D8-AECD-E80FF6790180 Q35276365-FF432759-D78A-4027-B4F2-68EF2F2B7CC8 Q35624697-05FC9309-90D1-4852-BEF6-F0FB78460D90 Q35848870-82C58FFA-DDBC-4F03-B987-0208038A1F5F Q36009246-2135CAC3-595C-405D-A86F-54E3D13B1853 Q36255465-8C36CD56-871D-4D25-8D1D-65F413EC9C64 Q36507182-AF6133AF-A4D4-4204-833C-7E6380DD44BD Q36622848-71A2B89A-E7BB-4D3F-8966-B96093646A49 Q36665073-0B34CF2D-7EA9-4013-9C0E-EDB16CD6877A Q36763762-F89AA030-7F8A-41CF-AA22-30B5DE9B3141 Q36796560-578857C9-3ADE-4D60-A8E3-86EBDF0D1727 Q36890788-D0612D5C-01F0-4492-8B12-8BEBD10C7583 Q36983874-F900E574-ACB1-4C27-97DC-96ED47F6AD52 Q36997333-ED772D71-462E-4DF6-B51E-FD95DC4A55E6 Q37026506-CE4354A4-1BD1-432D-AB46-47F578FA755C Q37058143-4D70360A-E4E0-4831-91FB-B380E49D1844 Q37199221-66EE13F6-FF9D-4B36-9168-6A63BF5C5FEB

P2860

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

http://www.wikidata.org/entity/Q37465068

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

@en

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

@nl

type

label

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

@en

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

@nl

prefLabel

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

@en

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

@nl

P1433

Q37465068-3580A201-A325-4021-BFA2-762F9281E7DA

P1476

Q37465068-2CA2D9C1-0677-4970-A065-EF0EA9AFC4D1

P2093

Q37465068-1EB561F2-86AE-4FCC-A19B-AE6C9A6BDE0C

Q37465068-41C53D0E-2046-4C90-8717-34A7A005A4F9

Q37465068-842E0646-1438-4E4D-BC6B-1848383366D0

Q37465068-8B3AEC76-4CA2-40C0-A624-F2C92ED7B098

Q37465068-94E51B98-2B44-44D3-87B6-06BA26A438F1

Q37465068-B6F19A44-903B-4D16-88EE-7AC140B917E7

Q37465068-EF4990E8-DC4B-4B0E-8013-3A5ED6BCA7DB

P2860

Q37465068-01417A1D-F29F-4403-999E-82B320385911

Q37465068-25FC8BBB-E2FF-4911-B4DF-AA3890EEB239

Q37465068-289FE9FC-1E7B-403F-BF37-1D13754588A9

Q37465068-29C308DF-5868-4EF2-A236-C35D170E9D20

Q37465068-2B0B7E13-7846-4EBB-B280-D93CB7EFAB7F

Q37465068-3C5961BD-AD7D-47F3-8E11-8799C29FA559

Q37465068-5C111A72-D043-47C9-B4DA-9911A4E971D4

Q37465068-6F4B406C-F077-4EAD-A19C-4941F1D1FBC3

Q37465068-70AF224E-B3E6-4F8D-AE32-539B3F48C186

Q37465068-72AF127B-3F43-4C52-8675-0627CCCF69ED

P304

Q37465068-28CC2920-D3BD-410B-B284-B34686C4A7C3

P31

Q37465068-CA931B4C-265F-4E4A-855B-CADB815DB6EC

P356

Q37465068-EA268BBA-385C-4FA0-80FA-A343721D4E72

P407

Q37465068-A4B3F5F5-BC9B-4E73-8415-66D47051236B

P433

Q37465068-882A5687-CC9C-48E6-A69A-F7CADE50FC7B

P478

Q37465068-791A4BCF-F492-4903-8B17-2CBB49EA7BE9

P577

Q37465068-4F25C3DB-856B-464E-BE13-C7D3ADC808DC

P698

Q37465068-C1C1CFE6-66DF-4FA4-A430-31BBA66E9986

P921

Q37465068-21429B6C-FD12-4990-8A82-72C3A24D85AF

Q37465068-43A82F44-3E6B-4B3B-A8A2-69713F4400EE

Q37465068-AE3A85BB-0F7E-492E-8A79-29914052E5F6

P932

Q37465068-9404CEFF-37E8-429C-87C3-C750781BF0CF

P356

WNL.0B013E3181C5B445

P1433

P1476

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease.

@en

P2093

A M Fagan

http://www.w3.org/2001/XMLSchema#string

A R Shah

http://www.w3.org/2001/XMLSchema#string

D B Clifford

http://www.w3.org/2001/XMLSchema#string

D M Holtzman

http://www.w3.org/2001/XMLSchema#string

J C Morris

http://www.w3.org/2001/XMLSchema#string

J S K Kauwe

http://www.w3.org/2001/XMLSchema#string

M Teshome

http://www.w3.org/2001/XMLSchema#string

P2860

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo

Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease

Prevalence of Alzheimer plaques in AIDS.

The search for antecedent biomarkers of Alzheimer's disease.

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients.

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

P304

1982-1987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3181C5B445

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19907013

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2790234

http://www.w3.org/2001/XMLSchema#string